Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meena B Bansal

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Hepatology International|September 1, 2016
Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are keyMeena B Bansal
Frontiers in Immunology|July 3, 2020
Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV InfectionLumin Zhang, Meena B Bansal
Nature Reviews. Gastroenterology & Hepatology|November 25, 2025
Liver disease in people living with HIV infection: a changing landscapeFrances Lee, Meena B Bansal
Hepatology International|October 11, 2018
Antifibrotics in liver disease: are we getting closer to clinical use?Meena B Bansal, Naichaya Chamroonkul
Hepatology International|January 31, 2019
Correction to: Antifibrotics in liver disease: are we getting closer to clinical use?Meena B Bansal, Naichaya Chamroonkul
Touchreviews in Endocrinology|June 14, 2023
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic SteatohepatitisGres Karim, Meena B Bansal
Hepatology (Baltimore, Md.)|February 1, 2006
Reversal of hepatic fibrosis -- fact or fantasy?Scott L Friedman, Meena B Bansal
Gastroenterology & Hepatology|September 29, 2023
Update on Clinical Trials for Nonalcoholic SteatohepatitisRohit R Nathani, Meena B Bansal
Alimentary Pharmacology & Therapeutics|March 7, 2024
Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicityShalini K Bansal, Meena B Bansal
Plos One|April 6, 2012
X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4Feng Hong, Yedidya Saiman, Chuanping Si, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Hepatology International|September 1, 2016
Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are keyMeena B Bansal
Frontiers in Immunology|July 3, 2020
Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV InfectionLumin Zhang, Meena B Bansal
Nature Reviews. Gastroenterology & Hepatology|November 25, 2025
Liver disease in people living with HIV infection: a changing landscapeFrances Lee, Meena B Bansal
Hepatology International|October 11, 2018
Antifibrotics in liver disease: are we getting closer to clinical use?Meena B Bansal, Naichaya Chamroonkul
Hepatology International|January 31, 2019
Correction to: Antifibrotics in liver disease: are we getting closer to clinical use?Meena B Bansal, Naichaya Chamroonkul
Touchreviews in Endocrinology|June 14, 2023
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic SteatohepatitisGres Karim, Meena B Bansal
Hepatology (Baltimore, Md.)|February 1, 2006
Reversal of hepatic fibrosis -- fact or fantasy?Scott L Friedman, Meena B Bansal
Gastroenterology & Hepatology|September 29, 2023
Update on Clinical Trials for Nonalcoholic SteatohepatitisRohit R Nathani, Meena B Bansal
Alimentary Pharmacology & Therapeutics|March 7, 2024
Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicityShalini K Bansal, Meena B Bansal
Plos One|April 6, 2012
X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4Feng Hong, Yedidya Saiman, Chuanping Si, et al.
Pageof 5